Your browser doesn't support javascript.
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid).
Abu-Raya, Bahaa; Migliori, Giovanni Battista; O'Ryan, Miguel; Edwards, Kathryn; Torres, Antoni; Alffenaar, Jan-Willem; Märtson, Anne-Grete; Centis, Rosella; D'Ambrosio, Lia; Flanagan, Katie; Hung, Ivan; Lauretani, Fulvio; Leung, Chi Chi; Leuridan, Elke; Maertens, Kirsten; Maggio, Marcello Giuseppe; Nadel, Simon; Hens, Niel; Niesters, Hubert; Osterhaus, Albert; Pontali, Emanuele; Principi, Nicola; Rossato Silva, Denise; Omer, Saad; Spanevello, Antonio; Sverzellati, Nicola; Tan, Tina; Torres-Torreti, Juan Pablo; Visca, Dina; Esposito, Susanna.
  • Abu-Raya B; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Migliori GB; Istituti Clinici Scientifici Maugeri, Istituto di Ricerca e Cura a Carattere Scientifico, Tradate, Italy.
  • O'Ryan M; Faculty of Medicine, Institute of Biomedical Sciences and Institute of Immunology and Immunotherapy, University of Chile, Santiago, Chile.
  • Edwards K; Vanderbilt University Medical Center, Nashville, TN, United States.
  • Torres A; Respiratory and Intensive Care Unit, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Alffenaar JW; Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia.
  • Märtson AG; Westmead Hospital, Sydney, NSW, Australia.
  • Centis R; Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, NSW, Australia.
  • D'Ambrosio L; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Flanagan K; Istituti Clinici Scientifici Maugeri, Istituto di Ricerca e Cura a Carattere Scientifico, Tradate, Italy.
  • Hung I; Public Health Consulting Group, Lugano, Switzerland.
  • Lauretani F; University of Tasmania, Monash University, RMIT University, Hobart, Australia.
  • Leung CC; Queen Mary Hospital, Hong Kong, China.
  • Leuridan E; Geriatric Clinic Unit, Department of Medicine and Surgery, University-Hospital of Parma, University of Parma, Parma, Italy.
  • Maertens K; Hong Kong Tuberculosis, Chest and Heart Diseases Association, Hong Kong, China.
  • Maggio MG; Faculty of Medicine and Health Sciences, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium.
  • Nadel S; Faculty of Medicine and Health Sciences, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium.
  • Hens N; Geriatric Clinic Unit, Department of Medicine and Surgery, University-Hospital of Parma, University of Parma, Parma, Italy.
  • Niesters H; St. Mary's Hospital, London, United Kingdom.
  • Osterhaus A; Data Science Institute, Hasselt University, Hasselt, Belgium.
  • Pontali E; Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Principi N; Universitair Medisch Centrum Groningen, Groningen, Netherlands.
  • Rossato Silva D; University of Veterinary Medicine, Hanover, Germany.
  • Omer S; Department of Infectious Diseases, Galliera Hospital, Genoa, Italy.
  • Spanevello A; Università degli Studi di Milano, Milan, Italy.
  • Sverzellati N; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
  • Tan T; Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, United States.
  • Torres-Torreti JP; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United States.
  • Visca D; Istituti Clinici Scientifici Maugeri, Istituto di Ricerca e Cura a Carattere Scientifico, Tradate, Italy.
  • Esposito S; Radiology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Front Med (Lausanne) ; 7: 572485, 2020.
Article in English | MEDLINE | ID: covidwho-1186815
ABSTRACT
Coronavirus disease 2019 (COVID-19) is a rapidly evolving, highly transmissible, and potentially lethal pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 11 2020, more than 7,000,000 COVID-19 cases have been reported worldwide, and more than 400,000 patients have died, affecting at least 188 countries. While literature on the disease is rapidly accumulating, an integrated, multinational perspective on clinical manifestations, immunological effects, diagnosis, prevention, and treatment of COVID-19 can be of global benefit. We aimed to synthesize the most relevant literature and experiences in different parts of the world through our global consortium of experts to provide a consensus-based document at this early stage of the pandemic.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Qualitative research / Reviews Language: English Journal: Front Med (Lausanne) Year: 2020 Document Type: Article Affiliation country: Fmed.2020.572485

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Qualitative research / Reviews Language: English Journal: Front Med (Lausanne) Year: 2020 Document Type: Article Affiliation country: Fmed.2020.572485